The work addresses a gap in biometric testing, as NIST’s IREX has focused primarily on closed-source commercial iris ...
To our knowledge, this study is the first to apply deep learning models that can, beyond diagnosis, identify molecular subtypes and predict outcomes in a single brain tumour entity (meningioma) using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results